Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
5
Ṁ110Ṁ152resolved Jan 2
Resolved
NO1H
6H
1D
1W
1M
ALL
The reporting must be within 2024, so if the reporting happens in January 2025 regarding Q4 2024, then this still resolves NO.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ46 | |
| 2 | Ṁ3 |
Sort by:
Best data I could find indicated about 1.8% of the US population on a GLP-1. The actual number may be higher, but per the definition, we need reporting.
@DavidFWatson Agreed, although the number of Americans taking GLP-1s may well exceed the threshold, I agree that there is no reliable reporting suggesting it is, the survey data available is not sufficient to establish.